Health
SARS-CoV-2 Neucleocapside (N) protein is heavily glycosylated – News-Medical.Net
However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint server bioRxiv in August 2020 reveals the structure of this protein, a val…
Eight months into the COVID-19 pandemic, there is still no fully protective therapy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has infected millions worldwide. Vaccines are being worked on in a host of institutions and countries, mostly targeting the spike protein of the virus. However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint s…
-
Business18 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News24 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Noosa News21 hours agoEverything To Know About Spilt Milk 2025
-
Noosa News12 hours agoEx-Townsville mayor Troy Thompson lied about army service, degrees, and cancer, says CCC